In clinical cellular cardiomyoplasty, bone marrow cells and myoblasts are introduced mainly to ischemic cardiomyopathy tissue via several cell delivery systems,
The paper presents the construction of an automatic applicator of active substance that removes causes of the disturbances in the fluid flow in a system that is